Diaceutics PLC

DIUXFOTCHealthcare● Active

$2.00

+$0.00(+0.00%)

Market Cap$169258896

P/E Ratio—

52W High$2.51

52W Low$1.3672

Avg Volume57

Open$2.00

Beta0.89

Free Cash Flow Financials Revenue

Diaceutics PLC (DIUXF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

DIUXF · free cash flow · updated Jun 9, 2026

Core FCF metrics

DIUXF · FCF · TTM · margin & CAGR

Free cash flow was $1.4M for FY2025 (fiscal year ending 2025-12-31), up 135.8% year-over-year The FCF margin was 3.7%.

FY2025 Free Cash Flow$1.4M▲ +135.8% YoY

Trailing 12M (TTM)$2.1Mtrailing 4 quarters sum

FCF Margin3.7%$1.4M ÷ revenue

3-Year CAGR+72.4%FY2022 → FY2025

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

DIUXF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.5M(0M)$1.4M▲ +135.8%3.7%

FY2024$651,000(5M)−$4.0M▼ 12.3%-12.4%

FY2023$1.3M(5M)−$3.5M▼ 1374.8%-14.9%

FY2022$5.1M(5M)$278,000▲ +105.5%1.4%

FY2021$570,000(6M)−$5.0M▲ +16.7%-36.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

DIUXF · P/FCF · FCF yield · FCF per share

Diaceutics PLC (DIUXF) trades at a FCF yield of 1.01% and a price-to-free-cash-flow ratio of 66.7x. FCF per share stands at $0.03, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

1.01%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.03

TTM FCF ÷ Shares Outstanding

Price / FCF

x66.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x94.0

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

DIUXF · cash flow statement · operating / investing / financing

For FY2025, Diaceutics PLC generated $1.5M in operating cash flow and spent 0M in capital expenditures, yielding $1.4M in free cash flow.

Operating Activities

+$1.5M

Cash from core business operations

2025-12-31

Investing Activities

−$6.4M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$0.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.5M) − |CapEx| (0M) = FCF ($1.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

DIUXF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Diaceutics PLCYOU

DIUXF

$1.4M+135.8%3.7%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Diaceutics PLC (DIUXF) reported free cash flow of $1.4M for FY2025 (fiscal year ending 2025-12-31), up 135.8% year-over-year. The FCF margin was 3.7%.

Based on available data, Diaceutics PLC has maintained positive free cash flow for at least 4 fiscal year(s). FCF peaked at $1.4M in FY2025.

Diaceutics PLC's FCF yield is 1.01% and price-to-FCF ratio is 66.7x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

DIUXF free cash flow · 8 questions

Diaceutics PLC free cash flow was $1.4M for FY2025, up 135.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $2.1M.

DIUXF free cash flowDIUXF FCFDIUXF FCF 2025DIUXF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Diaceutics PLC · Diaceutics PLC SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026